| Financial Year |
March 31 2023 |
| Monetary Funds |
255,755,106.43 |
| Held-for-trading Financial Assets |
23,760,592.42 |
| Notes Receivable |
283,935.00 |
| Accounts Receivable |
218,471,910.01 |
| Advances to Suppliers |
10,331,279.90 |
| Other Receivables |
18,858,360.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
73,692,594.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,023,279.79 |
| Total Current Assets |
632,560,803.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,237,452.19 |
| Investment Properties |
8,466,540.48 |
| Fixed Assetes |
154,733,590.88 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
24,983,891.17 |
| R&D expenses |
-- |
| Goodwill |
4,307,057.56 |
| Long-Term Deferred and Prepaid Expenses |
124,122,352.11 |
| Deferred Income Tax Assets |
20,323,937.96 |
| Other Non-Current Assets |
2,461,900.00 |
| Sub-Total of Non-Current Assets |
358,553,463.85 |
| Total Assets |
991,114,267.79 |
| Short-Term Loans |
80,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
109,785,469.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,871,750.51 |
| Taxes Payable |
30,887,923.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,633,795.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,794,749.74 |
| Other Current Liabilities |
3,002,476.94 |
| Sub-Total of Current Liabilities |
305,859,617.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,079,864.34 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,876,944.10 |
| Total Liabilities |
317,736,561.29 |
| Paid-In Capital(Or Share Stock) |
560,036,718.00 |
| Capital Surplus |
1,793,802,521.56 |
| Surplus Reserve |
61,461,678.97 |
| LESS:Treasury Stock |
41,924,400.00 |
| Undistributed Profits |
-1,683,985,499.06 |
| Minority Stockholder's Interest |
-1,417,873.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
674,795,580.11 |
| Owner's Equity（Stockholder's Equity） |
673,377,706.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
991,114,267.79 |
